CD226 and colorectal carcinoma: Overall, these sets of experiments show that CD226 expression selectively decreased in CD8+ TILs isolated from liver metastases of CRC patients compared to matched peripheral blood lymphocytes, regardless of checkpoint inhibitor expression.